These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 11765243
1. Duration of immunity induced by an adjuvanted and inactivated equine influenza, tetanus and equine herpesvirus 1 and 4 combination vaccine. Heldens JG, Kersten AJ, Weststrate MW, van den Hoven R. Vet Q; 2001 Nov; 23(4):210-7. PubMed ID: 11765243 [Abstract] [Full Text] [Related]
2. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95). Heldens JG, Pouwels HG, van Loon AA. Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389 [Abstract] [Full Text] [Related]
3. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares. Heldens JG, Hannant D, Cullinane AA, Prendergast MJ, Mumford JA, Nelly M, Kydd JH, Weststrate MW, van den Hoven R. Vaccine; 2001 Jul 20; 19(30):4307-17. PubMed ID: 11457558 [Abstract] [Full Text] [Related]
4. Concurrent vaccination against equine influenza and equine herpesvirus - a practical approach. Gildea S, Sanchez Higgins MJ, Johnson G, Walsh C, Cullinane A. Influenza Other Respir Viruses; 2016 Sep 20; 10(5):433-7. PubMed ID: 27169603 [Abstract] [Full Text] [Related]
5. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges. Patel JR, Földi J, Bateman H, Williams J, Didlick S, Stark R. Vet Microbiol; 2003 Mar 20; 92(1-2):1-17. PubMed ID: 12488066 [Abstract] [Full Text] [Related]
6. Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines. Bresgen C, Lämmer M, Wagner B, Osterrieder N, Damiani AM. Vet Microbiol; 2012 Nov 09; 160(1-2):9-16. PubMed ID: 22633483 [Abstract] [Full Text] [Related]
7. Primary vaccination in foals: a comparison of the serological response to equine influenza and equine herpesvirus vaccines administered concurrently or 2 weeks apart. Allkofer A, Garvey M, Ryan E, Lyons R, Ryan M, Lukaseviciute G, Walsh C, Venner M, Cullinane A. Arch Virol; 2021 Feb 09; 166(2):571-579. PubMed ID: 33410993 [Abstract] [Full Text] [Related]
8. Is there a benefit from an early booster vaccination in the control of equine influenza? Heldens JG, van Loon AA, van de Zande S. Vet J; 2007 Nov 09; 174(3):592-8. PubMed ID: 17560150 [Abstract] [Full Text] [Related]
9. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix. Heldens JG, Pouwels HG, Derks CG, Van de Zande SM, Hoeijmakers MJ. Vaccine; 2010 Oct 08; 28(43):6989-96. PubMed ID: 20728523 [Abstract] [Full Text] [Related]
10. Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination. Wilson WD, Mihalyi JE, Hussey S, Lunn DP. Equine Vet J; 2001 Nov 08; 33(7):644-50. PubMed ID: 11770984 [Abstract] [Full Text] [Related]
11. Serological responses of mares and weanlings following vaccination with an inactivated whole virus equine herpesvirus 1 and equine herpesvirus 4 vaccine. Foote CE, Love DN, Gilkerson JR, Whalley JM. Vet Microbiol; 2002 Aug 02; 88(1):13-25. PubMed ID: 12119135 [Abstract] [Full Text] [Related]
12. Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacHΔgM) confers partial protection against infection. Kydd JH, Hannant D, Robinson RS, Bryant N, Osterrieder N. Vaccine; 2020 Jan 10; 38(2):388-398. PubMed ID: 31629571 [Abstract] [Full Text] [Related]
13. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus. Holmes MA, Townsend HG, Kohler AK, Hussey S, Breathnach C, Barnett C, Holland R, Lunn DP. Vet Immunol Immunopathol; 2006 May 15; 111(1-2):67-80. PubMed ID: 16476488 [Abstract] [Full Text] [Related]
14. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals. Foote CE, Love DN, Gilkerson JR, Rota J, Trevor-Jones P, Ruitenberg KM, Wellington JE, Whalley JM. Vet Immunol Immunopathol; 2005 May 01; 105(1-2):47-57. PubMed ID: 15797474 [Abstract] [Full Text] [Related]
15. Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection. Patel JR, Didlick S, Bateman H. Equine Vet J; 2004 Jul 01; 36(5):447-51. PubMed ID: 15253088 [Abstract] [Full Text] [Related]
16. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination. Minke JM, Fischer L, Baudu P, Guigal PM, Sindle T, Mumford JA, Audonnet JC. Vet Immunol Immunopathol; 2006 May 15; 111(1-2):47-57. PubMed ID: 16580075 [Abstract] [Full Text] [Related]
17. Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine. Wagner B, Goodman LB, Babasyan S, Freer H, Torsteinsdóttir S, Svansson V, Björnsdóttir S, Perkins GA. Vaccine; 2015 Oct 13; 33(42):5588-5597. PubMed ID: 26384446 [Abstract] [Full Text] [Related]
18. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice. Liu SA, Stanfield BA, Chouljenko VN, Naidu S, Langohr I, Del Piero F, Ferracone J, Roy AA, Kousoulas KG. J Virol; 2017 Jun 15; 91(12):. PubMed ID: 28404844 [Abstract] [Full Text] [Related]
19. EHV-1 and EHV-4 infection in vaccinated mares and their foals. Foote CE, Love DN, Gilkerson JR, Wellington JE, Whalley JM. Vet Immunol Immunopathol; 2006 May 15; 111(1-2):41-6. PubMed ID: 16513181 [Abstract] [Full Text] [Related]